UNIVERSITY OF SOUTHERN CALIFORNIA
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1880-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://startusc.com
Study of Bortezomib and Docetaxel for Patients With Hormone Refractory Prostate Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2018-05-14
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 15
- Registration Number
- NCT00183937
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Study of Gemcitabine and Concurrent Radiation Followed by Adjuvant Hysterectomy in Bulky Stage Ib and IIa Cervical Carcinoma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 35
- Registration Number
- NCT00184093
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-04-11
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 50
- Registration Number
- NCT00184015
- Locations
- 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States
Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin's Lymphomas
- Conditions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 15
- Registration Number
- NCT00183976
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2019-05-16
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 75
- Registration Number
- NCT00183898
- Locations
- 🇺🇸
U.S.C./Norris Comprehensive Cancer Center, Los Angeles, California, United States
Intensified Post Remission Therapy Containing PEG-Asparaginase
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2014-05-22
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 47
- Registration Number
- NCT00184041
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
Study of Gemcitabine, Oxaliplatin, and Paclitaxel in Patients With Refractory Germ Cell Carcinoma
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-07-07
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 30
- Registration Number
- NCT00183820
- Locations
- 🇺🇸
Norris Comprehensive Cancer Center, Los Angeles, California, United States
Study of Irinotecan and Docetaxel in Patients With Metastatic or Unresectable Gastric or Gastroesophageal Junction Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 40
- Registration Number
- NCT00183872
- Locations
- 🇺🇸
University of Southern California (U.S.C.)/ Norris Comprehensive Cancer Center, Los Angeles, California, United States
Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
- Conditions
- Interventions
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2017-08-10
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 68
- Registration Number
- NCT00184002
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles, California, United States
A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
- First Posted Date
- 2005-09-16
- Last Posted Date
- 2018-05-16
- Lead Sponsor
- University of Southern California
- Target Recruit Count
- 76
- Registration Number
- NCT00183885
- Locations
- 🇺🇸
U.S.C. / Norris Comprehensive Cancer Center, Los Angeles, California, United States